Nivogli 0.3mg Tablet
Marketer
Nimbles Biotech Pvt Ltd
Salt Composition
Voglibose (0.3mg)
Overview Nivogli 0.3mg Tablet
Glimepiride 0.3mg tablets are prescribed for managing type 2 diabetes. This medication assists in regulating elevated post-prandial blood glucose. It's indicated when dietary modifications and other comparable treatments prove insufficient to manage hyperglycemia. Administer Glimepiride 0.3mg immediately before meals; dosage and frequency are determined by your physician for optimal glycemic control. Discontinue use only under medical supervision; abrupt cessation may cause dangerously high blood sugar, potentially leading to severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential. Common adverse reactions may include intestinal gas, abdominal discomfort, anorexia, constipation, and diarrhea. Report persistent or troublesome side effects to your physician. While Glimepiride alone rarely induces hypoglycemia, concurrent use with other antidiabetic agents (especially insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective. Inform your doctor of any kidney or liver issues prior to starting treatment. This medication is contraindicated in individuals with bowel inflammation or ulceration (e.g., ulcerative colitis, Crohn's disease). Pregnant or lactating women should consult their physician before use. Disclose all medications currently being taken to ensure safe usage. Limit alcohol consumption as it can elevate the risk of hypoglycemia.
Uses of Nivogli 0.3mg Tablet
Managing Type 2 Diabetes
Major Benefits of Nivogli 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Nivogli 0.3mg Tablets should be taken on an empty stomach.
Common Side effects of Nivogli 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Nivogli 0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the 0.3mg Nivogli tablet whole; do not chew, crush, or break it. Administer on an empty stomach.
How Nivogli 0.3mg Tablet works:
Nivogli 0.3mg tablets are used to manage diabetes. Their mechanism involves blocking enzymes in the intestines that digest complex carbohydrates, thus moderating postprandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Nivogli 0.3mg Tablet should not be taken with alcohol due to safety concerns.
PregnancySAFE IF PRESCRIBED
Use of the 0.3mg Nivogli tablet during pregnancy is generally deemed safe. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; however, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Based on limited available data in humans, breastfeeding mothers can likely use 0.3mg Nivogli tablets without significant risk to their infants.
DrivingSAFE
Driving ability is typically unaffected by the use of Nivogli 0.3mg tablets.
KidneyCAUTION
For individuals with severe kidney impairment, the use of 0.3mg Nivogli tablets requires careful monitoring. A modified dosage of 0.3mg Nivogli tablets may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using 0.3mg Nivogli tablets. Dosage modification for 0.3mg Nivogli tablets may be necessary. Physician consultation is advised.
What if you forget to take Nivogli 0.3mg Tablet :
Omit any missed 0.3mg Nivogli Tablet and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Nivogli 0.3mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Behavior Class | Alpha-glucosidase inhibitors |
3,018 People bought this recently